Spirea
Edit

Spirea

https://www.spirea.co.uk/
Last activity: 07.02.2023
Categories: UniversityTechnologyLifeEnterpriseDrugDevelopmentBuildingBioTech
Spirea, a biotech company spun out from the University of Cambridge, is committed to delivering the next generation of antibody drug conjugate (ADC) therapeutics to revolutionise cancer treatment and improve the lives of patients.
Mentions
10
Location: United Kingdom, England, Knaresborough
Employees: 11-50
Total raised: $5.91M
Founded date: 2017

Investors 6

Funding Rounds 2

DateSeriesAmountInvestors
14.06.2022-$2.91M-
14.06.2022-$3M-

Mentions in press and media 10

DateTitleDescriptionSource
07.02.2023#21toWatch announces shortlist of next generation of Cambrid...cofinitive have announced the shortlist for #21toWatch 2023 which this year contains an eclectic mix...cambridgen...
15.06.2022Sequoia Capital published 3 new survival guides for startupsThis is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ...fortune.co...
14.06.2022Spirea, a startup developing antibody drug conjugates in can...Cambridge-based biotech company Spirea has raised $3 million to advance a new generation of antibody...tech.eu/20...
14.06.2022Spirea Raises £2.4M ($3M) to Develop Antibody Drug Conjugate...-cambridgea...
14.06.2022Spirea Raises £2.4M in FundingSpirea Limited, a Cambridge, England, UK-based company created to advance a new generation of antibo...finsmes.co...
14.06.2022Spirea raises £2.4M ($3M) to develop antibody drug conjugate...Cambridge - Spirea Limited, a Cambridge company created to advance a new generation of antibody drug...cambridgen...
07.12.2020Spirea secures further financing to develop the next generat...Spirea secures further financing to develop the next generation of antibody drug conjugate therapeut...cambridgen...
07.12.2020Spirea secures further financing to develop the next generat...Spirea Limited, a spin-out from the University of Cambridge, which was founded to deliver the next g...cambridgen...
23.06.2020Shooting stars unveiled in Start Codon’s first contingentCambridge UK healthcare accelerator Start Codon has revealed its first cohort of early stage busines...cic.vc/new...
-Spirea, a startup developing antibody drug conjugates in can...Cambridge-based biotech company Spirea has raised $3 million to advance a new generation of antibody...tech.eu/20...

Reviews 0

Sign up to leave a review

Sign up Log In